keep sight steepen competit
met varian hc conf nyc read-
across ektab suggest increment pressur base busi
opportun follow run-up believ share increasingli
gear overli optimist launch expect present materi
downsid risk follow fy result revis ep
pt reiter under-perform
competit toughen base busi order sale grew
cer respect seem decent posit impact produce-
to-ord process implement order/instal adjust
order instal number lower order
sale adj comp respect indic base
busi seen minim growth last two year believ elekta would face
increment pressur varian grew sale order
period particular see pressur em varian halcyon system consid
sever larg em tender similar scale recent multi-system poland win
approv china expect year could lead order varian also expect
share gain underpin softwar convers
multipl hurdl limit opportun nich address market
unit product rise competit threat
note receiv cumul order mridian system instal
almost elekta order also process
upgrad imag resolut frame per second kilopixel
reduc instal time day given develop mridian
price cheaper vs uniti continu see downsid risk elekta
guidanc order price
model updat under-perform thesi unchang outlin believ
market significantli overestim commerci opportun price
unrealist bull case ektab resolv key issu mention rel
eas exce order guidanc price increas
ep mainli reflect restat fx movement lower financ
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
sale ebita miss con respect sale fell sequenti
lc flat order growth vs con decent
uninspir given soft comp larg order quantit
fy guidanc return lc sale growth margin bang
line vs con eight uniti order sign total long-stand
target previous
sale fell sequenti lc flat exhibit cyclic
inher market america emea apac order growth decent
uninspir lc vs particularli given soft comp growth
last fy growth driven mainli emea larg order america
improv yoy apac remain weak
updat eight new order bring total order vs target
eight addit order mri-guid linac place one us two
china five europ total order reach howev note
five order ppi europ worth total impli averag sell price
lower mid-point price guidanc in-lin
competitor price follow warn ektab offici
push long-stat target reach order compani
expect ce mark approv fda like follow
month later see downsid risk guidanc particular price
per unit unless meaning chang reimburs
return provid quantit fy guidanc expect sale growth
lc base howev long-standing margin target
trim like due delay launch ektab expect instal five
system china fy revenu would recognis post cfda approv
chart chang jefe estim
page
pleas see import disclosur inform page report
estimatesgroup sale ebita epsa vs million ep sekgroup sale ebitda ektab ss
chart sale
page
pleas see import disclosur inform page report
sale yoy yoy yoy yoy product oper income/ expens netebitda cost similar tax tax number share warrant ep ep per share sale growth growth capital-expenditure less ektab ss
page
pleas see import disclosur inform page report
balanc current tangibl fix intang inc gwtotal fix account short-term debt sharehold ex work oper item flow oper invest free financ flow credit debt equiti ratio debt payabl ektab ss
driver chang
updat model post result reflect fx impact lower tax rate restat
page
pleas see import disclosur inform page report
